An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

about

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

Item

http://www.wikidata.org/entity/Q57093877

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 12 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@en

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@nl

type

Item

label

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@en

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@nl

altLabel

Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine

@en

prefLabel

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@en

An alternative strategy as a quadrivalent live attenuated influenza virus vaccine

@nl

P1476

Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine

@en

P2093

Daniela Rajao

http://www.w3.org/2001/XMLSchema#string

Ginger Geiger

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Silvia Carnaccini

http://www.w3.org/2001/XMLSchema#string

Zhimin Wan

http://www.w3.org/2001/XMLSchema#string

P2860

Influenza: evolving strategies in treatment and prevention

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

Mortality associated with influenza and respiratory syncytial virus in the United States

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

A DNA transfection system for generation of influenza A virus from eight plasmids

Toward a universal influenza virus vaccine: prospects and challenges.

A review of vaccine research and development: human acute respiratory infections.

DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.

P31

scholarly article

P356

10.1128/JVI.01025-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel R. Perez

Jefferson José da Silva Santos

Stivalis Cardenas-Garcia

Lucas Ferreri

P577

2018-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30135124

http://www.w3.org/2001/XMLSchema#string

P921

immunology

attenuated vaccine

virology

P932

6189493

http://www.w3.org/2001/XMLSchema#string